April 2020
Our response to the COVID-19 pandemic has been to ensure all our staff in the UK, USA and India are equipped for home-working and are fully aware of the need to comply with all their national government restrictions on social distancing, travel etc. We foresee no interruption to services and ask our customers to continue logging support requests via our Customer Login.
The World Health Organization (WHO) has published interim guidance to laboratories and stakeholders involved in COVID-19 virus laboratory testing of patients. It is based in part on the interim guidance on laboratory testing for Middle East respiratory syndrome (MERS) coronavirus. Download available: https://apps.who.int/iris/handle/10665/331501
Due to the COVID-19 pandemic, many of our industry’s exhibitions and conferences have been cancelled or postponed. Our Events list has been updated and we will continue to post any changes on this list as they are announced.
In response to the COVID-19 pandemic, Eli Lilly and Company has delayed most new study starts and paused enrollment in most ongoing studies. However, it is continuing ongoing clinical trials for patients who are already enrolled: https://investor.lilly.com/news-releases/news-release-details/lilly-provides-update-clinical-trial-activities-during-covid-19
Archive
- July 2022
- June 2022
- April 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020